Immune thrombocytopenic purpura following human papillomavirus vaccination

Vaccine

Volumn 27, Issue 28, 2009, Pages 3690-

  Pugnet, Gregory ^a   Ysebaert, Loïc ^b   Bagheri, Haleh ^a   Montastruc, Jean Louis ^a   Laurent, Guy ^b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b CHU PURPAN   (France)

Author keywords

Human papillomavirus vaccine; Immune thrombocytopenic purpura

Indexed keywords

PREDNISOLONE; THROMBOCYTE ANTIBODY; WART VIRUS VACCINE;

ADOLESCENT; ANTIBODY DETECTION; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOFLUORESCENCE; LETTER; PRIORITY JOURNAL; THROMBOCYTE COUNT; VACCINATION;

ADOLESCENT; FEMALE; HUMANS; PAPILLOMAVIRUS VACCINES; PURPURA, THROMBOCYTOPENIC;

EID: 65649096950     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.004     Document Type: Letter

References (3)

1. Arbyn M., and Dillner J. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for the Quality Assurance in Cervical Cancer Screening. J Clin Virol 38 (2007) 189-197
2. http://www.who-umc.org/graphics/4409.pdf
3. Chen R.T., Pless R., and Destefano F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun 16 (2001) 309-318